Clomiphene vs Toremifene: side-by-side comparison
Clomid · Clomiphene Citrate · Serophene
A first-generation SERM that is a mixture of two isomers: 62% enclomiphene (trans, antagonist) and 38% zuclomiphene (cis, agonist). Works primarily at the hypothalamus to block estrogen negative feedback, increasing GnRH pulsatility and subsequent LH/FSH release. Produces a stronger initial LH/FSH spike than tamoxifen but with more side effects, particularly vision issues.
Fareston · Toremifene Citrate · Torem
A first-generation triphenylethylene SERM, structurally almost identical to tamoxifen (Nolvadex), differing by a single chlorine substitution. Like tamoxifen it is an estrogen antagonist in breast tissue and at the hypothalamus/pituitary (raising LH/FSH) while acting estrogenically in bone and liver. It is used off-label for post-cycle therapy and gynecomastia. Its main practical distinctions from tamoxifen are a stronger positive effect on blood lipids, a lower blood-clot risk, metabolism by a different liver enzyme (so it dodges tamoxifen's SSRI interaction problem), and a QT-prolongation warning that tamoxifen lacks.
2 / 10 natty scale / 2
Same lane
Both sit in the same class and are run for pct, health. This is a like-for-like comparison: read the gaps as real trade-offs.
The tape
Core ratings
The same three rulers every entry on the site is scored with, read head to head.
Natty scale
1 natural · 10 heavy
Effectiveness
Documented effect · of 5
Side-effect severity
Documented burden · of 5
Cost side
Body-load fingerprint
Where each one actually lands its strain, on the calculator's thirteen channels. Tap a row for what it means and which labs track it.
Cardiometabolic
Organ strain
Hormonal
Systemic
Bars show strain at each one's typical protocol, not your dose. ≈ marks values inferred from side-effect data or category rather than hand-graded. For your numbers, run the calculator.
Logistics
The vitals
Benefit side
What each is for
Shared goals carry both dots; a goal with one dot belongs to that side alone.
Run for
Documented upside
- Stronger initial LH/FSH spike than tamoxifen
- Preserves and restores fertility (unlike TRT)
- Maintains intratesticular testosterone for spermatogenesis
- Well-established use since 1960s
- Can be used long-term for hypogonadism
Run for
Documented upside
- Effective PCT SERM - raises LH, FSH and natural testosterone
- Strong gynecomastia prevention/treatment
- Does not lower systemic estradiol (preserves estrogen's benefits, unlike an AI)
- More favorable effect on lipids than tamoxifen
- Lower blood-clot (VTE) risk than tamoxifen
The downsides
Side effects, aligned
Each entry's documented side effects, sorted onto the same body systems so the gaps and the overlaps are visible. Tap any effect for the detail.
None documented
None documented
The exit
Hormonal fallout & recovery
What each does to your own hormone axis while on, and what leaving it costs.
Clomiphene
Clomiphene IS a PCT drug. Standard protocol: 50/50/25/25 (mg/day for 4 weeks). Can be combined with Nolvadex for enhanced recovery. Start 3-5 days after last oral steroid, or 2-3 weeks after last long-ester injection.
Toremifene
Toremifene IS a PCT drug. Typical protocol: 120/90/60/30 mg/day over 4 weeks (taper), or flat 60 mg/day for 4-6 weeks. Can be combined with clomiphene/enclomiphene and/or preceded by HCG for enhanced recovery. Start 3-5 days after the last oral/short-ester dose, or 2-3 weeks after the last long-ester injection. Like tamoxifen, use caution stacking with 19-nor compounds (see interactions).
Read-out
How they separate
- 01
Enhancement
They land at almost the same point on the natty scale (2/10 vs 2/10): a similar distance beyond natural.
- 02
Body load
The widest gap at typical protocols is blood thickness (Toremifene 3.2/10 vs 0/10), then liver strain (Toremifene 2.8/10 vs 0/10).
- 03
Coming off
Neither requires PCT: both leave the natural testosterone axis running.
- 04
Tested athletes
Both are WADA-prohibited: neither belongs anywhere near tested competition.
Generated from each entry's data file. Descriptive, not a recommendation; nothing here is medical advice.